Obstetricians and psychiatrists are involved a couple of current FDA panel spreading misinformation in regards to the potential harms of utilizing SSRIs throughout being pregnant and postpartum.
AYESHA RASCOE, HOST:
Ought to pregnant girls and new moms take antidepressants? A current Meals and Drug Administration panel raised questions in regards to the security of those medicine. An estimated 6% to eight% of pregnant girls take antidepressants referred to as SSRIs. Medical doctors and psychiatrists treating these sufferers say the FDA panel misrepresented proof and unfold misinformation. NPR’s Rhitu Chatterjee is right here to inform us extra. Rhitu, thanks.
RHITU CHATTERJEE, BYLINE: Pleased to be right here, Ayesha.
RASCOE: So I perceive you watched the FDA panel. What precisely did the panelists say?
CHATTERJEE: So the FDA commissioner, Marty Makary, opened the occasion, framing the entire dialogue round these so-called potential harms of a gaggle of tension and melancholy medicine referred to as SSRIs, that are medicines like Zoloft and Lexapro. After which a majority of panelists, together with some psychiatrists, psychologists, a social work professor, cited research they are saying illustrate well being dangers to each mother and child. One panelist – Roger McFillin, a psychologist from Pennsylvania – steered that ladies really feel coerced into taking these medicines and that melancholy is overdiagnosed in girls.
(SOUNDBITE OF ARCHIVED RECORDING)
ROGER MCFILLIN: Is that as a result of this underlying psychological sickness that we’re attempting to manage for – one we do not check for when there isn’t a goal testing – it simply is extra prevalent in girls? Or are girls simply naturally experiencing their feelings extra intensely? And people are presents. They are not signs of a illness.
CHATTERJEE: Now, to be clear, psychiatrists use a particular set of standards to diagnose melancholy and nervousness. And an individual has to have had 5 or extra of these standards for a melancholy analysis, and simply feeling overly emotional is not sufficient to be recognized.
RASCOE: What are medical doctors and psychiatrists saying in regards to the panel’s claims of harms attributable to SSRI use in being pregnant?
CHATTERJEE: So a number of well being care teams and organizations have launched statements in opposition to these claims and stated that they’re deceptive. Now, responding to that critique, Andrew Nixon, spokesperson for the federal Well being Division, informed NPR in an electronic mail that the declare that the panel was, quote, “one-sided” is, quote, “insulting” to the panelists.
Now, I spoke with Dr. Christopher Zahn, chief of scientific apply with the American Faculty of Obstetricians and Gynecologists – or ACOG – one of many teams pushing again on a number of the panel’s claims. He defined why the research cited by most panelists had been what he described as poor-quality proof or nonevidence-based.
CHRISTOPHER ZAHN: So should you’re evaluating a pregnant affected person who has taken an SSRI, the management group ought to be the pregnant affected person with psychological well being abnormalities who hasn’t taken an SSRI. And a part of the issue with a lot of these research – they do not use the proper management group. And actually, it is sort of like evaluating apples and oranges.
CHATTERJEE: You already know, Dr. Zahn informed me that well-controlled research do not discover this affiliation of SSRI use with these well being dangers that the panelists talked about. Now, the one threat that does present up is for newborns of mothers who take the medicine within the third trimester. And the infants can have some withdrawal signs, however they resolve on their very own in a couple of days. And in line with him and most others within the area, the underside line is these research which have adopted lots of of 1000’s of ladies discover that the majority SSRIs are protected for pregnant and postpartum girls.
RASCOE: What in regards to the people who find themselves simply attempting to determine whether or not they need to take these medicine after they’re pregnant or simply after giving start? What are the principle issues they should know?
CHATTERJEE: So firstly, Ayesha, is that there are dangers of not treating their signs at this stage of life. The adverse penalties on the well being of each mother and child are very well-documented. This is Dr. Kay Roussos-Ross. She’s an OBGYN on the College of Florida, and she or he was the one individual on the FDA panel to spell these harms out.
KAY ROUSSOS-ROSS: When psychological well being situations go untreated, these girls are much less more likely to attend their prenatal care appointments, they usually’re extra doubtless to make use of substances throughout their being pregnant. They’re additionally extra more likely to face further dangers reminiscent of preeclampsia and cesarean supply.
CHATTERJEE: And psychological sickness is a number one reason for maternal deaths on this nation, together with deaths because of suicide. Now, I ought to add that SSRIs aren’t the one possibility for treating nervousness and melancholy throughout and after being pregnant. For these with gentle to reasonable melancholy and nervousness, , speak remedy is the primary and most suitable choice. There’s additionally peer assist. However for these with reasonable to extreme melancholy and people who are having bother accessing speak remedy, which is an enormous problem, then antidepressants are an possibility. Now, it will not be proper for everybody, however discuss all of this together with your physician. Weigh all of it in opposition to the chance of not treating your signs.
RASCOE: That is NPR’s Rhitu Chatterjee. Thanks a lot.
CHATTERJEE: My pleasure.
Copyright © 2025 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional data.
Accuracy and availability of NPR transcripts could fluctuate. Transcript textual content could also be revised to appropriate errors or match updates to audio. Audio on npr.org could also be edited after its unique broadcast or publication. The authoritative report of NPR’s programming is the audio report.
